Skin quality vs. structure — why the best results layer both
Medically reviewed by
The LovMedSpa medical team, led by Dr. Ahmed Elsoury, MD and Dr. Mark Ennett, MD
Last reviewed: June 2026
Skin quality and facial structure are different problems — different tissue layers, different mechanisms, different tools. Resurfacing treatments (laser, RF microneedling, chemical peels) work at the epidermal and dermal surface: they improve texture, tone, dyschromia (uneven pigmentation), pore appearance, and the fine static rhytids that accumulate from sun exposure and time. Structural treatments — biostimulators, HA filler, neuromodulators — address what sits underneath: collagen loss, volume depletion, laxity, and the muscle dynamics that drive deeper lines. Treating only one axis produces a result that is identifiably incomplete, and the specific character of the incompleteness reveals exactly which one was skipped. The results that hold up consistently are the ones that address both.
Why surface treatment alone underdelivers
The most common version of this pattern: a patient invests in good resurfacing — smooth texture, even tone, reduced pore appearance, improved surface uniformity — and still reads as tired or older than they feel. The surface improvement is real, but it sits on a substrate that hasn't changed. Resurfacing modalities work within the epidermis and upper dermis; they do not restore the midface volume lost to fat compartment descent and collagen depletion, cannot lift soft tissue that has descended below its original anatomical position, and have no mechanism for replacing the structural collagen that accounts for the progressive hollowing of the temples, periorbital area, and lower face that begins in the mid-30s. A fractional CO₂ laser treats the surface of skin overlying a hollowed midface; it does not change the hollow. The result reads as polished but still aged — because the aging visible in the structural layer is unaddressed. Clinically, this is the "refreshed but not quite right" outcome that patients often struggle to name: the skin is objectively better, but the overall appearance hasn't moved in the direction they expected.
Why structural treatment alone also underdelivers
The inverse failure is equally common. A patient with well-maintained structure — biostimulator protocols, HA filler in the appropriate zones, consistent neuromodulator — whose skin surface has deteriorated from UV accumulation, post-inflammatory hyperpigmentation (PIH), or atrophic scarring (the depressed scar pattern from acne, injury, or stretch marks). Filler adds volume beneath compromised skin; it does not improve the skin itself. Botulinum toxin relaxes the muscles driving dynamic rhytids (expression lines) but has no effect on the epidermal layer — it does not resurface, repigment, or remodel texture. Biostimulators trigger deep neocollagenesis in the dermis, which can improve overall skin quality modestly, but they are not a substitute for a targeted resurfacing protocol. The structural patient who skips surface treatment ends up with sound three-dimensional architecture under skin that reads as damaged or fatigued — a face with good bones and poor surface, where the mismatch is itself the thing that reads as wrong. This is the "they clearly take care of themselves but something is still off" observation — often visible in photographs, where surface quality is exposed by flash and lighting more brutally than structure.
How quality and structure compound each other
The compounding effect runs in both directions. Structural restoration done before resurfacing means the surface treatment is applied to tissue in its correct, restored position — not to skin overlying a deficit that will be corrected afterward. Resurfacing done after volume is in place treats the right surface, which makes the result more accurate and reduces the likelihood of needing to repeat surface work once structural corrections shift the underlying tissue. The parallel also applies within the collagen axis: RF microneedling delivers thermal energy to the reticular dermis at the same tissue depth that biostimulators are triggering neocollagenesis — two concurrent collagen-induction mechanisms reinforcing the same remodeling process from slightly different angles. Neuromodulators compound with resurfacing in a specific way: tox stops the muscular motion that continuously re-etches dynamic lines; resurfacing treats the static lines those repetitive contractions have already etched at rest. Used together, tox prevents the line from deepening further while resurfacing addresses what has already accumulated — neither alone achieves both. And the broadest compounding effect: a face with restored structural volume reads its surface-quality improvements more authentically. Resurfaced skin on a hollowed face looks smooth and hollow. The same resurfacing on a structurally restored face reads as rested, healthy, and genuinely younger — because the two layers of improvement are working in the same direction rather than against each other.
Common questions
Which should I address first — skin quality or structure?
Structure typically goes first. Resurfacing done on a structurally depleted face treats skin in a different position than it will occupy after volume is restored — the surface work may be partially repeated once the structural layer is in place. Collagen-stimulating resurfacing done after structural restoration also finds better-quality tissue to work with, deepening the result. The exception is when a primary surface concern — significant active post-inflammatory hyperpigmentation or deep acne scarring — needs to be cleared before a structural assessment is meaningful.
Can RF microneedling address both skin quality and structure?
Partially — and this is one of RF microneedling's clinical advantages. Needle depth and energy parameters are calibrated to specific tissue planes: superficial dermis settings address fine texture, pore size, and surface quality; deeper reticular dermis settings address mild laxity and structural remodeling. It is not a substitute for biostimulator-level collagen restoration or HA filler volume correction — but within a combined plan, it usefully addresses both axes at its appropriate depth range, in a single treatment series.
How do I know whether I need quality work, structural work, or both?
The assessment is anatomical, not preferential. Significant hollowing under the eyes, flattening of the midface, or visible laxity in the jawline and neck points toward structural priority. Rough texture, uneven pigmentation, visible pores, or atrophic acne scarring points toward surface quality. Most patients over 35 have measurable needs on both axes — the question is sequencing and relative emphasis, not choosing one. A clinical assessment gives the actual map; self-diagnosis from photos tends to overweight what's most visible in current lighting, which is almost always surface quality.
At LovMedSpa, treatment plans are built around both axes — skin quality and structural integrity — under the oversight of medical director Dr. Ahmed Elsoury, MD (New York and Connecticut) and Dr. Mark Ennett, MD (South Florida), across our Brooklyn, Manhattan, Staten Island, Aventura, and West Farms locations. A consultation maps both axes — what the tissue needs and in what order — rather than recommending a single modality in isolation.
This is general information, not medical advice; individual treatment planning across quality and structural goals is determined by a licensed provider at consultation.